ASX:BOT Botanix Pharmaceuticals (BOT) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.63 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield2.96%Price TargetN/A Stock AnalysisStock Analysis Get Botanix Pharmaceuticals alerts: Email Address Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About Botanix Pharmaceuticals Stock (ASX:BOT)Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in Leederville, Australia.Read More Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. BOT Stock News HeadlinesSeptember 2, 2024 | msn.comEvening Wrap: ASX 200 starts September on winning note as big bank rally extends, gold, uranium, and lithium stocks weakerAugust 31, 2024 | finance.yahoo.comBotanix Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues LagSeptember 16, 2024 | The Freeport Society (Ad)Elon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.July 27, 2024 | finance.yahoo.comBotanix Pharmaceuticals Limited (BXPHF)July 23, 2024 | msn.comTop performing funds: A high-conviction idea from a manager that delivered 35% in FY24May 26, 2024 | finance.yahoo.comASX Growth Companies With High Insider Ownership Spotlight May 2024May 15, 2024 | morningstar.comBotanix Pharmaceuticals Ltd BXPHFApril 30, 2024 | finance.yahoo.comWe're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn RateSeptember 16, 2024 | The Freeport Society (Ad)Elon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.March 8, 2024 | wsj.comBotanix Pharmaceuticals Ltd.January 23, 2024 | investing.comBotanix Pharmaceuticals Ltd (BOT)January 23, 2024 | fool.com.auIf you'd put $40,000 in this ASX healthcare stock at the start of 2023, you'd have $128,000 nowDecember 14, 2023 | morningstar.comBotanix Pharmaceuticals Ltd BOTOctober 12, 2023 | finance.yahoo.comBotanix Pharmaceuticals (ASX:BOT) shareholders have earned a 138% return over the last yearSeptember 26, 2023 | fool.com.auGuess which ASX cannabis share is crashing 36% following an FDA blowSeptember 20, 2023 | fool.com.auThis ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!September 1, 2023 | finance.yahoo.comBotanix Pharmaceuticals Full Year 2023 Earnings: AU$0.008 loss per share (vs AU$0.014 loss in FY 2022)August 12, 2023 | finanznachrichten.deFresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateSee More Headlines Receive BOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Botanix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today9/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:BOT CUSIPN/A CIKN/A Webwww.botanixpharma.com Phone+61-8-94820580FaxN/AEmployees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,870,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-21.07% Return on Assets-12.74% Debt Debt-to-Equity Ratio0.19 Current Ratio22.21 Quick Ratio1.26 Sales & Book Value Annual Sales$2.07 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.50 Book ValueA$0.06 per share Price / BookN/AMiscellaneous Outstanding Shares1,810,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.71 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Vincent P. Ippolito (Age 65)MD & Executive Chairman Comp: $364.85kDr. Howie McKibbonChief Executive OfficerMr. Matthew Callahan L.L.B. (Age 51)M.B.A., MBA LLB, Executive Director Comp: $385.52kDr. Jack Hoblitzell Ph.D.Senior Vice President of Pharmaceutical DevelopmentDr. Patricia S. Walker M.D. (Age 65)Ph.D., Chief Medical Adviser Key Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All Competitors BOT Stock Analysis - Frequently Asked Questions How were Botanix Pharmaceuticals' earnings last quarter? Botanix Pharmaceuticals Limited (ASX:BOT) issued its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. What other stocks do shareholders of Botanix Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Botanix Pharmaceuticals investors own include Byron Energy (BYE), Harmony Gold Mining (HMY), Puhui Wealth Investment Management (PHCF), NIKE (NKE), Michael Hill International (MHJ) and Lynas Rare Earths (LYC). This page (ASX:BOT) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredGrab this ETF paying a huge 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Botanix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Botanix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
